Rxo (RXO) Change in Cash (2021 - 2026)

Rxo (RXO) has reported Change in Cash for 6 consecutive years, with $4.0 million the latest figure, recorded in Q1 2026.

• Change in Cash for Q1 2026 came in at $4.0 million, up 121.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.0 million (down 33.33% YoY), and the FY2025 annual result was -$17.0 million, down 156.67% from the prior year.
• Change in Cash was $4.0 million for Q1 2026 at Rxo, up from -$8.0 million in the prior quarter.
• Over five years, Change in Cash peaked at $166.0 million in Q2 2022 and troughed at -$99.0 million in Q4 2023.
• Average Change in Cash over 5 years is -$437500.0, with a median of $2.5 million recorded in 2023.
• Year-over-year, Change in Cash sank 4350.0% in 2022 and jumped 340.0% in 2024.
• Over 5 years, Change in Cash stood at -$89.0 million in 2022, then fell by 11.24% to -$99.0 million in 2023, then surged by 79.8% to -$20.0 million in 2024, then soared by 60.0% to -$8.0 million in 2025, then soared by 150.0% to $4.0 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were $4.0 million in Q1 2026, -$8.0 million in Q4 2025, and $7.0 million in Q3 2025.